Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
DOX vs CNXC vs TTEC vs EPAM vs CTSH
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
Information Technology Services
DOX vs CNXC vs TTEC vs EPAM vs CTSH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Information Technology Services | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $6.91B | $1.71B | $132M | $5.24B | $24.49B |
| Revenue (TTM) | $4.58B | $9.83B | $2.10B | $5.56B | $21.41B |
| Net Income (TTM) | $572M | $-1.28B | $-201M | $387M | $2.23B |
| Gross Margin | 37.6% | 33.3% | 15.5% | 27.9% | 32.1% |
| Operating Margin | 17.7% | 6.2% | 4.3% | 9.9% | 15.7% |
| Forward P/E | 8.5x | 2.1x | 2.2x | 7.7x | 9.1x |
| Total Debt | $826M | $4.64B | $1.00B | $144M | $1.57B |
| Cash & Equiv. | $325M | $327M | $83M | $1.30B | $1.90B |
DOX vs CNXC vs TTEC vs EPAM vs CTSH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Amdocs Limited (DOX) | 100 | 96.9 | -3.1% |
| Concentrix Corporat… (CNXC) | 100 | 30.3 | -69.7% |
| TTEC Holdings, Inc. (TTEC) | 100 | 4.0 | -96.0% |
| EPAM Systems, Inc. (EPAM) | 100 | 30.8 | -69.2% |
| Cognizant Technolog… (CTSH) | 100 | 66.1 | -33.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DOX vs CNXC vs TTEC vs EPAM vs CTSH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DOX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.53, yield 3.1%
- 34.1% 10Y total return vs EPAM's 41.5%
- 12.5% margin vs CNXC's -13.0%
- Beta 0.53 vs TTEC's 1.83, lower leverage
CNXC is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (2.1x vs 7.7x)
Among these 5 stocks, TTEC doesn't own a clear edge in any measured category.
EPAM ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 15.4%, EPS growth -14.3%, 3Y rev CAGR 4.2%
- Lower volatility, beta 1.11, Low D/E 3.9%, current ratio 2.59x
- 15.4% revenue growth vs DOX's -9.4%
CTSH is the clearest fit if your priority is valuation efficiency and defensive.
- PEG 0.75 vs EPAM's 2.07
- Beta 0.71, yield 2.4%, current ratio 2.34x
- 10.9% ROA vs TTEC's -14.2%, ROIC 18.7% vs 6.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.4% revenue growth vs DOX's -9.4% | |
| Value | Lower P/E (2.1x vs 7.7x) | |
| Quality / Margins | 12.5% margin vs CNXC's -13.0% | |
| Stability / Safety | Beta 0.53 vs TTEC's 1.83, lower leverage | |
| Dividends | 3.1% yield, 12-year raise streak, vs CNXC's 5.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -28.8% vs CNXC's -50.6% | |
| Efficiency (ROA) | 10.9% ROA vs TTEC's -14.2%, ROIC 18.7% vs 6.2% |
DOX vs CNXC vs TTEC vs EPAM vs CTSH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DOX vs CNXC vs TTEC vs EPAM vs CTSH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DOX leads in 3 of 6 categories
CNXC leads 1 • CTSH leads 1 • TTEC leads 0 • EPAM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DOX leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CTSH is the larger business by revenue, generating $21.4B annually — 10.2x TTEC's $2.1B. DOX is the more profitable business, keeping 12.5% of every revenue dollar as net income compared to CNXC's -13.0%. On growth, EPAM holds the edge at +7.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.6B | $9.8B | $2.1B | $5.6B | $21.4B |
| EBITDAEarnings before interest/tax | $1.0B | $773M | $178M | $696M | $3.9B |
| Net IncomeAfter-tax profit | $572M | -$1.3B | -$201M | $387M | $2.2B |
| Free Cash FlowCash after capex | $755M | $572M | $102M | $544M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +37.6% | +33.3% | +15.5% | +27.9% | +32.1% |
| Operating MarginEBIT ÷ Revenue | +17.7% | +6.2% | +4.3% | +9.9% | +15.7% |
| Net MarginNet income ÷ Revenue | +12.5% | -13.0% | -9.6% | +7.0% | +10.4% |
| FCF MarginFCF ÷ Revenue | +16.5% | +5.8% | +4.9% | +9.8% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.1% | +4.3% | -7.1% | +7.6% | +5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +9.0% | -14.9% | -6.6% | +18.8% | +3.7% |
Valuation Metrics
CNXC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.4x trailing earnings, CTSH trades at a 23% valuation discount to EPAM's 14.8x P/E. Adjusting for growth (PEG ratio), CTSH offers better value at 0.94x vs EPAM's 3.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.9B | $1.7B | $132M | $5.2B | $24.5B |
| Enterprise ValueMkt cap + debt − cash | $7.4B | $6.0B | $1.0B | $4.1B | $24.2B |
| Trailing P/EPrice ÷ TTM EPS | 12.62x | -1.19x | -0.68x | 14.77x | 11.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.55x | 2.07x | 2.24x | 7.69x | 9.07x |
| PEG RatioP/E ÷ EPS growth rate | 1.98x | — | — | 3.98x | 0.94x |
| EV / EBITDAEnterprise value multiple | 7.28x | 4.78x | 5.67x | 6.32x | 5.92x |
| Price / SalesMarket cap ÷ Revenue | 1.53x | 0.17x | 0.06x | 0.96x | 1.16x |
| Price / BookPrice ÷ Book value/share | 2.05x | 0.56x | 1.16x | 1.52x | 1.66x |
| Price / FCFMarket cap ÷ FCF | 10.72x | 2.98x | 1.62x | 8.54x | 9.44x |
Profitability & Efficiency
CTSH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
DOX delivers a 16.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-100 for TTEC. EPAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to TTEC's 8.86x. On the Piotroski fundamental quality scale (0–9), DOX scores 6/9 vs TTEC's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.5% | -33.2% | -99.6% | +10.7% | +14.8% |
| ROA (TTM)Return on assets | +9.0% | -10.8% | -14.2% | +8.1% | +10.9% |
| ROICReturn on invested capital | +15.6% | +5.6% | +6.2% | +15.5% | +18.7% |
| ROCEReturn on capital employed | +16.8% | +6.6% | +7.5% | +13.3% | +21.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.24x | 1.69x | 8.86x | 0.04x | 0.10x |
| Net DebtTotal debt minus cash | $501M | $4.3B | $917M | -$1.2B | -$326M |
| Cash & Equiv.Liquid assets | $325M | $327M | $83M | $1.3B | $1.9B |
| Total DebtShort + long-term debt | $826M | $4.6B | $1.0B | $144M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 23.45x | -3.07x | -4.22x | — | 107.78x |
Total Returns (Dividends Reinvested)
DOX leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DOX five years ago would be worth $9,521 today (with dividends reinvested), compared to $521 for TTEC. Over the past 12 months, DOX leads with a -28.8% total return vs CNXC's -50.6%. The 3-year compound annual growth rate (CAGR) favors CTSH at -3.5% vs TTEC's -53.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -19.8% | -39.4% | -24.1% | -50.5% | -36.0% |
| 1-Year ReturnPast 12 months | -28.8% | -50.6% | -32.3% | -44.8% | -33.2% |
| 3-Year ReturnCumulative with dividends | -22.9% | -67.1% | -89.9% | -57.2% | -10.3% |
| 5-Year ReturnCumulative with dividends | -4.8% | -80.6% | -94.8% | -78.4% | -22.4% |
| 10-Year ReturnCumulative with dividends | +34.1% | -62.5% | -63.1% | +41.5% | -0.4% |
| CAGR (3Y)Annualised 3-year return | -8.3% | -31.0% | -53.5% | -24.6% | -3.5% |
Risk & Volatility
DOX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DOX is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than TTEC's 1.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOX currently trades 66.8% from its 52-week high vs CNXC's 39.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.53x | 1.33x | 1.83x | 1.11x | 0.71x |
| 52-Week HighHighest price in past year | $95.41 | $62.14 | $5.60 | $222.53 | $87.03 |
| 52-Week LowLowest price in past year | $62.75 | $22.85 | $1.98 | $98.76 | $50.19 |
| % of 52W HighCurrent price vs 52-week peak | +66.8% | +39.1% | +48.4% | +44.6% | +59.4% |
| RSI (14)Momentum oscillator 0–100 | 48.5 | 44.7 | 55.2 | 20.7 | 27.6 |
| Avg Volume (50D)Average daily shares traded | 962K | 1.6M | 672K | 1.3M | 5.8M |
Analyst Outlook
Evenly matched — DOX and CNXC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DOX as "Buy", CNXC as "Buy", TTEC as "Hold", EPAM as "Buy", CTSH as "Hold". Consensus price targets imply 1160.9% upside for TTEC (target: $34) vs 41.2% for DOX (target: $90). For income investors, CNXC offers the higher dividend yield at 5.86% vs CTSH's 2.45%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $90.00 | $52.00 | $34.17 | $158.00 | $81.75 |
| # AnalystsCovering analysts | 11 | 9 | 14 | 37 | 51 |
| Dividend YieldAnnual dividend ÷ price | +3.1% | +5.9% | — | — | +2.4% |
| Dividend StreakConsecutive years of raises | 12 | 5 | 0 | — | 9 |
| Dividend / ShareAnnual DPS | $2.01 | $1.42 | — | — | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +8.0% | +11.1% | 0.0% | 0.0% | +5.6% |
DOX leads in 3 of 6 categories (Income & Cash Flow, Total Returns). CNXC leads in 1 (Valuation Metrics). 1 tied.
DOX vs CNXC vs TTEC vs EPAM vs CTSH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DOX or CNXC or TTEC or EPAM or CTSH a better buy right now?
For growth investors, EPAM Systems, Inc.
(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus -9. 4% for Amdocs Limited (DOX). Cognizant Technology Solutions Corporation (CTSH) offers the better valuation at 11. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Amdocs Limited (DOX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DOX or CNXC or TTEC or EPAM or CTSH?
On trailing P/E, Cognizant Technology Solutions Corporation (CTSH) is the cheapest at 11.
4x versus EPAM Systems, Inc. at 14. 8x. On forward P/E, Concentrix Corporation is actually cheaper at 2. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cognizant Technology Solutions Corporation wins at 0. 75x versus EPAM Systems, Inc. 's 2. 07x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DOX or CNXC or TTEC or EPAM or CTSH?
Over the past 5 years, Amdocs Limited (DOX) delivered a total return of -4.
8%, compared to -94. 8% for TTEC Holdings, Inc. (TTEC). Over 10 years, the gap is even starker: EPAM returned +41. 5% versus TTEC's -63. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DOX or CNXC or TTEC or EPAM or CTSH?
By beta (market sensitivity over 5 years), Amdocs Limited (DOX) is the lower-risk stock at 0.
53β versus TTEC Holdings, Inc. 's 1. 83β — meaning TTEC is approximately 244% more volatile than DOX relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 9% for TTEC Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DOX or CNXC or TTEC or EPAM or CTSH?
By revenue growth (latest reported year), EPAM Systems, Inc.
(EPAM) is pulling ahead at 15. 4% versus -9. 4% for Amdocs Limited (DOX). On earnings-per-share growth, the picture is similar: TTEC Holdings, Inc. grew EPS 40. 8% year-over-year, compared to -648. 8% for Concentrix Corporation. Over a 3-year CAGR, CNXC leads at 15. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DOX or CNXC or TTEC or EPAM or CTSH?
Amdocs Limited (DOX) is the more profitable company, earning 12.
5% net margin versus -13. 0% for Concentrix Corporation — meaning it keeps 12. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOX leads at 18. 2% versus 4. 5% for TTEC. At the gross margin level — before operating expenses — DOX leads at 36. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DOX or CNXC or TTEC or EPAM or CTSH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Cognizant Technology Solutions Corporation (CTSH) is the more undervalued stock at a PEG of 0. 75x versus EPAM Systems, Inc. 's 2. 07x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Concentrix Corporation (CNXC) trades at 2. 1x forward P/E versus 9. 1x for Cognizant Technology Solutions Corporation — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TTEC: 1160. 9% to $34. 17.
08Which pays a better dividend — DOX or CNXC or TTEC or EPAM or CTSH?
In this comparison, CNXC (5.
9% yield), DOX (3. 1% yield), CTSH (2. 4% yield) pay a dividend. TTEC, EPAM do not pay a meaningful dividend and should not be held primarily for income.
09Is DOX or CNXC or TTEC or EPAM or CTSH better for a retirement portfolio?
For long-horizon retirement investors, Amdocs Limited (DOX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 3. 1% yield). TTEC Holdings, Inc. (TTEC) carries a higher beta of 1. 83 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DOX: +34. 1%, TTEC: -63. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DOX and CNXC and TTEC and EPAM and CTSH?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DOX is a small-cap deep-value stock; CNXC is a small-cap income-oriented stock; TTEC is a small-cap quality compounder stock; EPAM is a small-cap high-growth stock; CTSH is a mid-cap deep-value stock. DOX, CNXC, CTSH pay a dividend while TTEC, EPAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.